STOCKHOLM, March 29, 2023 /PRNewswire/ -- EQT Life Sciences has held the final close of its inaugural LSP Dementia Fund ("the Fund"), raising approximately EUR 260 million in fee-generating assets under management, meeting the hard cap and surpassing the target fund size of EUR 100 million. The fund is dedicated to investing in companies that are developing breakthrough drug therapies and medical technologies across the spectrum of neurodegenerative diseases.
Read more at prnewswire.comEQT Life Sciences closes Dementia Fund at the hard cap
PR Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here